I love stuff that serves multiple purposes and Rosemary certainly qualifies. While it’s lovely planted,  or in a pot by the entry to your home where the wind can blow it’s beautiful fragrance to greet you or guests, in this post I’d like to share why it’s so awesome combined with Bacopa for personal care and why you should want to be using it daily on your scalp.

Reason one you should massage your scalp with it…it increases brain power!  While you may have heard Rosemary can help with memory, a new study from Miami Children’s Hospital Research Center studied extracts of Rosemary and Bacopa together can be even more therapeutic. The herbal extracts were tested together and seperately on human brain and nerve cells and the results found the combination of the two to be most effective at halting the production of amyloid proteins(precedes tau tangle formations linked with Alzhemiers). Awesome right?

Reason two you should massage your scalp with it..it reduces hair loss and encourages new growth! Rosemary has been tested against Minoxidil(the only topical treatment for hair regrowth approved by the U.S. FDA) and has shown to be just as effective at promoting hair growth NATURALLY  WITHOUT the side effects. Bacopa promotes hair growth by prolonging the anagen phase(similar to eyelash growth serums). Pure awesomeness.

For these reasons the synergy of these herbs are used in salonsolids dry shampoo. To support your mind and hair health. Delivered in plastic free PCR paper tubes to be used in glass or stainless steel refillables for the health of our planet.  <3

References- realnatural.org  Ramachandran C, Quirin KW, Escalon E, Melnick SJ. Improved neuroprotective effects by combining Bacopa monnieri and Rosmarinus officinalis supercritical CO2 extracts. J Evid Based Complementary Altern Med. 2014 Apr;19(2):119-27. doi: 10.1177/2156587214524577Panahi Y, Taghizadeh M, Marzony ET, Sahebkar A. Rosemary oil vs minoxidil 2% for the treatment of androgenetic alopecia: a randomized comparative trial. Skinmed. 2015 Jan-Feb;13(1):15-21.